NL-OMON51316
Recruiting
Not Applicable
An observational, non-interventional cohort study to monitor physical and social activity of bladder cancer patients during treatment with curative intent by using conventional and digital methodology - Digital monitoring of bladder cancer patients (eBladder)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Bladder cancer
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Able to provide written informed consent.
- •2\. Patients suspected of or with pathologically confirmed diagnosis of bladder
- •cancer, with as predominant type urothelial carcinoma or squamous cell
- •a. Before or after undergoing TURBT.
- •b. Before starting the rest of their treatment.
- •3\. \>\= 18 years at screening.
- •4\. Has the ability to communicate well in Dutch with the investigator and
- •willing to comply with the study instructions.
Exclusion Criteria
- •1\. Permanent and temporary alterations on the wrist, including tattoos.
- •2\. Inability to wear or use wearables and other digital devices.
- •3\. Inability or limitations to walk or move at screening, or use of walking
- •4\. History of allergy to surgical steel.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Digital monitoring of bladder cancer patients (eBladder)Bladder cancerCancerISRCTN55744047Amsterdam University Medical Centers50
Completed
Not Applicable
This study is to survey on venous thromboembolism risk in cancer patients (lung or colorectal) who were about to start a new chemotherapy regimen.Health Condition 1: null- Colorectal or Lung (SCLC or NSCLC) cancerHealth Condition 2: C349- Malignant neoplasm of unspecifiedpart of bronchus or lungCTRI/2013/02/003380Sanofi Synthelabo India Ltd4,300
Active, not recruiting
Phase 4
This non-interventional observational study (CRAD001H2406) is to evaluate recurrence of hepatocellular carcinoma (HCC) until Month 60 post-transplantation in liver transplant recipients with primary HCC at liver transplantatioHealth Condition 1: K742- Hepatic fibrosis with hepatic sclerosisCTRI/2019/10/021760ovartis Healthcare Pvt Ltd1
Completed
Not Applicable
ongitudinal non-interventional observational study on Adherence, safety and tolerability of AVANZ® in adults and GRAZAX® and SLIToneULTRA® in adults and children (5 – 17 years) in patients with allergic Rhinoconjunctivitis in GErmanyJ30.1J30.3Allergic rhinitis due to pollenOther allergic rhinitisDRKS00005069ALK-Abelló Arzneimittel GmbH2,571
Active, not recruiting
Not Applicable
The impact of rotavirus vaccine introduction in SAsevere gastroenteritisInfection - Other infectious diseasesACTRN12611000559910Children, Youth and Women's health Service200